Composition for the prevention of muscle fatique and skeletal muscle adaptation of strenuous exercise
AssigneeSigma-Tau HealthScience S.p.A.
InventorClaudio Cavazza
Life of this patent
Estimating the term…
Abstract
A composition is disclosed suitable for the prevention and/or treatment of muscular energetic deficiencies and states of asthenia for enhancing sport performances and for the treatment of states of heart fatigue, that may take the form of a dietary supplement, dietetic support or of an actual medicine, which comprises as characterizing active ingredients a combination of L-carnitine and/or at least one alkanoyl L-carnitine and creatinol-phosphate.
Claims7
An orally, parenterally, rectally or transdermally administrable combination composition which comprises the following components:
- (a) at least one carnitine selected from the group consisting of L-carnitine, acetyl L-carnitine, propionyl L-carnitine, butyryl L-carnitine, valeryl L-carnitine and isovaleryl L-carnitine or a pharmacologically acceptable salt thereof, and
- (b) 1-(2-hydroxyethyl)-1-methylguanidine-O-phosphate or a pharmacologically acceptable salt thereof.
A method of preventing or treating muscular energetic deficiencies, asthenia, muscle fatigue, heart fatigue, post-infarct heart conditions or enhancing sporting performances, said method comprising orally, parenterally, rectally or transdermally administering a combination comprising the following components:
- (a) at least one carnitine selected from the group consisting of L-carnitine, acetyl L-carnitine, propionyl L-carnitine, butyryl L-carnitine, valeryl L-carnitine and isovaleryl L-carnitine or a pharmacologically acceptable salt thereof, and
- (b) 1-(2-hydroxyethyl)-1-methylguanidine-O-phosphate or a pharmacologically acceptable salt thereof.
Dependencies are inferred from the claim text.